Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008?

KR Siegel, MK Ali, X Zhou, BP Ng, S Jawanda… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE To synthesize updated evidence on the cost-effectiveness (CE) of interventions
to manage diabetes, its complications, and comorbidities. RESEARCH DESIGN AND …

Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review

R Li, P Zhang, LE Barker, FM Chowdhury… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE To synthesize the cost-effectiveness (CE) of interventions to prevent and control
diabetes, its complications, and comorbidities. RESEARCH DESIGN AND METHODS We …

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European …

L Rydén, E Standl, M Bartnik… - European heart …, 2007 - academic.oup.com
Task Forces, expert groups, or consensus panels. The chosen experts in these writing
panels are asked to provide disclosure statements of all relationships they may have, which …

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

B Hemmingsen, SS Lund, C Gluud… - Cochrane Database …, 2013 - cochranelibrary.com
Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of
cardiovascular disease and mortality compared to the background population …

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

B Hemmingsen, SS Lund, C Gluud, A Vaag, T Almdal… - Bmj, 2011 - bmj.com
Objective To assess the effect of targeting intensive glycaemic control versus conventional
glycaemic control on all cause mortality and cardiovascular mortality, non-fatal myocardial …

Blood pressure control for diabetic retinopathy

DV Do, G Han, SA Abariga, G Sleilati… - Cochrane Database …, 2023 - cochranelibrary.com
Background Diabetic retinopathy is a common complication of diabetes and a leading cause
of visual impairment and blindness. Research has established the importance of blood …

Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence

R Rodríguez-Gutiérrez, VM Montori - … : Cardiovascular Quality and …, 2016 - Am Heart Assoc
Background—We sought to determine the concordance between the accumulating evidence
about the impact of tight versus less tight glycemic control in patients with type 2 diabetes …

[HTML][HTML] The potential effect of metformin on cancer: an umbrella review

H Yu, X Zhong, P Gao, J Shi, Z Wu, Z Guo… - Frontiers in …, 2019 - frontiersin.org
Background: Metformin has been reported to possess anti-cancer properties in addition to
glucose-lowering activity and numerous systematic reviews and meta-analyses have …

Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting

S Petrou, A Gray - Bmj, 2011 - bmj.com
Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and
reporting | The BMJ Skip to main content Intended for healthcare professionals Access …

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis

CL Gillies, PC Lambert, KR Abrams, AJ Sutton… - Bmj, 2008 - bmj.com
Objective To compare four potential screening strategies, and subsequent interventions, for
the prevention and treatment of type 2 diabetes:(a) screening for type 2 diabetes to enable …